Ashleigh Levison, MD
Retina Specialist · Lafayette, CONPI 1508093485
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. AbbVie accounts for 76.6% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $19,236 and has fallen 92.7% since, to $1,407 in 2025.
Across 136 payments — averaging $241.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$25K
- Carl Zeiss Meditec, Inc.$3K
- Genentech, Inc.$1K
- Alcon$522
- Apellis Pharmaceuticals, Inc.$421
- Genentech USA, Inc.$368
- plus $2K from 16 others
What the payments were for
- Consulting fees$5,60017%
- Speaking & faculty fees$18,35056%
- Travel & lodging$2,6868%
- Food & beverage$6,14919%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 44 | $25,102 |
| Carl Zeiss Meditec, Inc. | 4 | $2,765 |
| Genentech, Inc. | 7 | $1,219 |
| Alcon | 5 | $522 |
| Apellis Pharmaceuticals, Inc. | 5 | $421 |
| Genentech USA, Inc. | 5 | $368 |
| Novartis | 8 | $331 |
| Regeneron Healthcare Solutions, Inc. | 11 | $318 |
| Eyepoint US, Inc. | 8 | $305 |
| Bausch & Lomb Americas Inc. | 7 | $271 |
| Astellas Pharma US Inc | 8 | $202 |
| Astellas Pharma Global Development | 1 | $164 |
| Topcon Healthcare, Inc. | 2 | $150 |
| Amgen | 2 | $134 |
| Coherus Oncology, Inc. | 4 | $117 |
| Biogen | 2 | $97 |
| Heidelberg Engineering, Inc. | 1 | $76 |
| Harrow Eye, LLC | 4 | $73 |
| ANI Pharmaceuticals, Inc. | 3 | $53 |
| Boston Scientific | 2 | $39 |
| Alimera Sciences, Inc. | 2 | $37 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Humira$17,619
- OZURDEX$6,790
- IOLMaster$2,600
- VABYSMO$828
- SUSVIMO$397
- Syfovre$236
- Non-Covered Product$167
- Izervay$164
- Clareon$149
- XIPERE$148
- XEN GLAUCOMA TREATMENT SYSTEM$125
- EYLEA HD$125
- TEPEZZA$117
- Lucentis$111
- ARTEVO 800$110
How this compares
$32,784 in reported general payments places this provider in the 85th percentile of 51 retina specialist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 17 | $152,093 |
| Prednisolone Acetate | 187 | $7,672 |
| Difluprednate | 36 | $3,840 |
| ValacyclovirValacyclovir Hcl | 27 | $1,905 |
| Brimonidine Tartrate | 85 | $963 |
| Atropine Sulfate | 16 | $642 |
| Ciprofloxacin Hcl | 65 | $605 |
| Ketorolac Tromethamine | 25 | $594 |
| Dorzolamide Hcl | 29 | $549 |
| Latanoprost | 62 | $504 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 24 | $398 |
| Timolol Maleate | 63 | $281 |
| Prednisone | 20 | $122 |
| MethotrexateMethotrexate Sodium | 12 | $112 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Lafayette
- Robert CourtneyLafayette$7K
- Murtaza AdamParker$548K
- Alan KimuraDenver$546K
- Brian JoondephDenver$92K
- Talisa ForestAurora$84K
- Sara HaugDurango$59K
- Matthew ManryLongmont$43K
- Mimi LiuEnglewood$23K
- Moss FenbergDurango$20K
- Lynn HassmanAurora$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.